Cancer Clinical Investigation

Search results

• La UB és la universitat de l’Estat amb més investigadors entre els més influents del món

  Llovet, J.

  21/11/24

  1 item of Media coverage

  Press/Media

• Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai to offer joint Ph.D. program in health sciences engineering

  Vashishth,, D., Charney, D. & Balchandani, P.

  20/11/24

  1 item of Media coverage

  Press/Media

• Mount Sinai Health System: Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai to Offer Joint PhD Program in Health Sciences Engineering

  Vashishth,, D. & Balchandani, P.

  20/11/24

  1 item of Media coverage

  Press/Media

• PreciseDx Announces Formation of Scientific Advisory Board

  Cordon-Cardo,, C. & Sparano, J.

  20/11/24

  4 items of Media coverage

  Press/Media

• PreciseDx Announces Formation of Scientific Advisory Board

  Cordon-Cardo,, C. & Sparano, J.

  20/11/24

  1 item of Media coverage

  Press/Media

• Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai to Offer Joint PhD Program in Health Sciences Engineering

  Vashishth,, D., Charney, D. & Balchandani, P.

  20/11/24

  2 items of Media coverage

  Press/Media

• Clinical Trial: Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion

  Sfakianos, J.

  19/11/24

  2 items of Media coverage

  Press/Media

• Studies from Icahn School of Medicine at Mount Sinai in the Area of Thyroid Cancer Reported (Pathologic Characteristics and Surgical Outcomes of Pediatric Versus Adult Well-differentiated Thyroid Cancer)

  Kumar, A., van Gerwen, M., Kirke,, D. & Roof, S.

  19/11/24

  1 item of Media coverage

  Press/Media

• Clinical Trials – November 19, 2024 Alligator Bioscience presents new trial results Alligator Bioscience and Aptevo Therapeutics report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, with more than half of evaluable pat

  Marron, T.

  19/11/24

  1 item of Media coverage

  Press/Media

• Nine researchers from the Clínic-IDIBAPS among the most highly cited researchers according to Clarivate Analytics

  Llovet, J.

  19/11/24

  1 item of Media coverage

  Press/Media

• Weekly: Karyopharm Therapeutics (KPTI: 81.40c) shares post worst week in eleven weeks; -6.28c [7.2%]

  Mascarenhas, J.

  16/11/24

  1 item of Media coverage

  Press/Media

• Drug delays tumour growth in models of children's liver cancer

  Llovet, J.

  15/11/24

  1 item of Media coverage

  Press/Media

• NYU Langone Hospitals: Remote Telemedicine Tool Found Highly Accurate in Diagnosing Melanoma

  Gulati, N.

  14/11/24 → 15/11/24

  3 items of Media coverage

  Press/Media

• Remote Telemedicine Tool Found Highly Accurate In Diagnosing Melanoma

  Gulati, N.

  14/11/24

  1 item of Media coverage

  Press/Media

• Remote Telemedicine Tool Found Highly Accurate In Diagnosing Melanoma

  Gulati, N.

  14/11/24

  72 items of Media coverage

  Press/Media

• Reports Summarize Sensor Research Study Results from Icahn School of Medicine at Mount Sinai (Radiofrequency Enhancer to Recover Signal Dropouts in 7 Tesla Diffusion MRI)

  Verma, G., Balchandani, P. & Alipour, A.

  14/11/24

  1 item of Media coverage

  Press/Media

• Antelope Surgical Solutions Achieves Commercial Investigational New Drug (IND) Approval for PSMA-Fluorescent Novel Drug AS1986NS

  Tewari, A.

  13/11/24

  1 item of Media coverage

  Press/Media

• First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial

  Marron, T.

  13/11/24

  1 item of Media coverage

  Press/Media

• The Tisch Cancer Institute at Mount Sinai Highlights Key Developments for Lung Cancer Awareness Month 2024

  Hirsch, F., Hirsch, F., Henschke, C., Flores, R. & Taioli, E.

  13/11/24

  1 item of Media coverage

  Press/Media

• Antelope Surgical Solutions Achieves Commercial Investigational New Drug (IND) Approval For PSMA-Fluorescent Novel Drug AS1986NS

  Tewari, A.

  12/11/24

  68 items of Media coverage

  Press/Media

• -Aptevo Therapeutics - First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial

  Marron, T.

  11/11/24 → 12/11/24

  3 items of Media coverage

  Press/Media

• Antelope Surgical Solutions Achieves Commercial Investigational New Drug (IND) Approval For PSMA-Fluorescent Novel Drug AS1986NS

  Tewari, A.

  12/11/24

  1 item of Media coverage

  Press/Media

• Studies from Icahn School of Medicine at Mount Sinai Have Provided New Information about Radical Cystectomy (Undetectable Pre-radical Cystectomy Circulating Tumour Dna Status Predicts Improved Oncological Outcomes)

  Mehrazin,, R., Sfakianos, J., Wiklund, P. & Attalla, K.

  12/11/24

  1 item of Media coverage

  Press/Media

• First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial

  Marron, T.

  11/11/24

  12 items of Media coverage

  Press/Media

• 08:43 EST Aptevo announces ALG.APV-527 meets trial endpoints in Phase 1 study

  Marron, T.

  11/11/24

  1 item of Media coverage

  Press/Media